A pharma giant is moving past one patent cliff — but another is already looming
“This medicine could be one of our largest medicines in history,” Novartis CEO Vas Narasimhan told CNBC on Tuesday, as the Swiss drugmaker backed remibrutinib,…
Tag: Spdr S&P Pharmaceuticals Etf